These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31375337)

  • 1. Serum soluble Fas ligand levels and peripheral blood lymphocyte subsets in patients with drug-induced maculopapular rashes, dress, and viral exanthemas.
    Yazicioglu M; Gokmirza Ozdemir P; Turgut B; Sut N
    Allergol Immunopathol (Madr); 2020; 48(4):339-347. PubMed ID: 31375337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble FAS ligand: a discriminating feature between drug-induced skin eruptions and viral exanthemas.
    Stur K; Karlhofer FM; Stingl G
    J Invest Dermatol; 2007 Apr; 127(4):802-7. PubMed ID: 17139262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions.
    Komatsu-Fujii T; Kaneko S; Chinuki Y; Suyama Y; Ohta M; Niihara H; Morita E
    Allergol Int; 2017 Jan; 66(1):116-122. PubMed ID: 27497618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
    Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
    Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cytotoxic proteins correlates with liver function impairment in patients with drug reaction with eosinophilia and systemic symptoms (DRESS).
    Yang F; Chen SA; Wu X; Zhu Q; Luo X
    Eur J Dermatol; 2018 Feb; 28(1):13-25. PubMed ID: 29521632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y; Shinkuma S; Nakamura-Nishimura Y; Ommori R; Ogawa K; Miyagawa F; Mori Y; Tohyama M; Asada H
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):558-565.e4. PubMed ID: 34757063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-ligand staining in non-drug- and drug-induced maculopapular rashes.
    Wang EC; Lee JS; Tan AW; Tang MB
    J Cutan Pathol; 2011 Feb; 38(2):196-201. PubMed ID: 20726934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of FasL mRNA, sFasL and their regulatory effect on T lymphocyte subsets in patients with severe acute pancreatitis].
    Qin Y; Liao P; He S; Yin Y; Song S; Hu J; Zheng P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1189-92. PubMed ID: 24200068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between DRESS and the diminished numbers of peripheral B lymphocytes and natural killer cells.
    Yazicioglu M; Elmas R; Turgut B; Genchallac T
    Pediatr Allergy Immunol; 2012 May; 23(3):289-96. PubMed ID: 22432939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression Fas and FasL antigen protein of lymphocytes T and B in hypertrophied adenoid in children with otitis media with effusion].
    Zelazowska-Rutkowska B; Wysocka J; Ratomski K; Skotnicka B; Zak J; Mrugacz M
    Otolaryngol Pol; 2008; 62(1):59-64. PubMed ID: 18637423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
    Jun EJ; Han JY; Sun HS
    Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
    Morito H; Ogawa K; Fukumoto T; Kobayashi N; Morii T; Kasai T; Nonomura A; Kishimoto T; Asada H
    Clin Exp Dermatol; 2014 Apr; 39(3):284-91. PubMed ID: 24635062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
    Kano Y; Hirahara K; Mitsuyama Y; Takahashi R; Shiohara T
    Allergy; 2007 Dec; 62(12):1439-44. PubMed ID: 17983378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
    Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.
    Kozlowski M; Kowalczuk O; Sulewska A; Dziegielewski P; Lapuc G; Laudanski W; Niklinska W; Chyczewski L; Niklinski J; Laudanski J
    Folia Histochem Cytobiol; 2007; 45(3):199-204. PubMed ID: 17951168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
    Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in serum levels of soluble Fas and soluble FasL in patients with multiple organ dysfunction syndrome].
    Fu Y; Xiao QM; Wang T; Chen XH; Ai YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Nov; 18(11):691-4. PubMed ID: 17092425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
    Panasiuk A; Parfieniuk A; Zak J; Flisiak R
    Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.